Marco Girhard

Dr. Marco Girhard

orcid

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2012 in Trends in Biotechnology
Verified
Journal Article
Closed access
VUVlada B. Urlacher
Vlada B. Urlacher
MGMarco Girhard
Marco Girhard

1 August 2019 in Trends in Biotechnology
Verified
Journal Article
Closed access
VUVlada B. Urlacher
Vlada B. Urlacher
MGMarco Girhard
Marco Girhard

1 October 2007 in Biochemical and Biophysical Research Communications
Verified
Journal Article
Closed access
MGMarco Girhard
Marco Girhard
SSStefanie Schuster
Stefanie Schuster
MDMatthias Dietrich
Matthias Dietrich
PDPeter Dürre
Peter Dürre
VUVlada B. Urlacher
Vlada B. Urlacher

26 February 2010 in Applied Microbiology and Biotechnology
Verified
Journal Article
Closed access
PDF file
MGMarco Girhard
Marco Girhard
TKTobias Klaus
Tobias Klaus
YKYogan Khatri
Yogan Khatri
RBRita Bernhardt
Rita Bernhardt
VUVlada B. Urlacher
Vlada B. Urlacher

10 July 2009 in Microbial Cell Factories
Verified
Journal Article
Open access
PDF file
MGMarco Girhard
Marco Girhard
KMKazuhiro Machida
Kazuhiro Machida
MIMasashi Itoh
Masashi Itoh
RSRolf D Schmid
Rolf D Schmid
AAAkira Arisawa
Akira Arisawa
VUVlada B Urlacher
Vlada B Urlacher
Background: (+)-Nootkatone (4) is a high added-value compound found in grapefruit juice. Allylic oxidation of the sesquiterpene (+)-valencene (1) provides an attractive route to this sought-after flavoring. So far, chemical methods to produce (+)-nootkatone (4) from (+)-valencene (1) involve unsafe toxic compounds, whereas several biotechnological approaches applied yield large amounts of undesirable byproducts. In the present work 125 cytochrome P450 enzymes from bacteria were tested for regioselective oxidation of (+)-valencene (1) at allylic C2-position to produce (+)-nootkatone (4) via cis- (2) or trans-nootkatol (3). The P450 activity was supported by the co-expression of putidaredoxin reductase (PdR) and putidaredoxin (Pdx) from Pseudomonas putida in Escherichia coli. Results: Addressing the whole-cell system, the cytochrome CYP109B1 from Bacillus subtilis was found to catalyze the oxidation of (+)-valencene (1) yielding nootkatol (2 and 3) and (+)-nootkatone (4). However, when the in vivo biooxidation of (+)-valencene (1) with CYP109B1 was carried out in an aqueous milieu, a number of undesired multi-oxygenated products has also been observed accounting for approximately 35% of the total product. The formation of these byproducts was significantly reduced when aqueous-organic two-liquid-phase systems with four water immiscible organic solvents – isooctane, n-octane, dodecane or hexadecane – were set up, resulting in accumulation of nootkatol (2 and 3) and (+)-nootkatone (4) of up to 97% of the total product. The best productivity of 120 mg l-1 of desired products was achieved within 8 h in the system comprising 10% dodecane. Conclusion: This study demonstrates that the identification of new P450s capable of producing valuable compounds can basically be achieved by screening of recombinant P450 libraries. The biphasic reaction system described in this work presents an attractive way for the production of (+)-nootkatone (4), as it is safe and can easily be controlled and scaled up.

25 January 2013 in Biotechnology and Applied Biochemistry
Verified
Journal Article
Closed access
PDF file
MGMarco Girhard
Marco Girhard
EKElmar Kunigk
Elmar Kunigk
STSvetlana Tihovsky
Svetlana Tihovsky
VSVictoria V. Shumyantseva
Victoria V. Shumyantseva
VUVlada B. Urlacher
Vlada B. Urlacher